Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHaydale Plc Regulatory News (HAYD)

Share Price Information for Haydale Plc (HAYD)

Share Price is delayed by 15 minutes
Get Live Data
0.325    0.00 (0.00%)
Bid:
0.32
Ask:
0.33
Spread: 0.01 (3.125%)
Market Cap: £25.27m
HAYD Live PriceLast checked at - London Stock Exchange

Intraday Haydale Plc Share Chart

Distribution Agreement

21 Jul 2014 07:01

HAYDALE GRAPHENE INDUSTRIES PLC - Distribution Agreement

HAYDALE GRAPHENE INDUSTRIES PLC - Distribution Agreement

PR Newswire

London, July 20

Haydale Graphene Industries plc ("Haydale" or the "Company") Announces Distribution Agreement with Goodfellow Cambridge Limited Haydale Graphene Industries plc (AIM:HAYD), the Company focused on enablingtechnology for the commercialisation of graphene, is pleased to announce it hasentered into a distribution agreement with Goodfellow Cambridge Limited("Goodfellow") ("Agreement"), widely regarded as one of the premier globaldistributors of advanced materials for R&D, prototyping and specialisedmanufacturing. The Agreement is a rolling annual contract and will focus on the globalmarketing and distribution of Haydale HDPlas® functionalised graphenenanoplatelets (GNPs) to major research and industrial clients throughGoodfellow's international network. Ray Gibbs, CEO at Haydale, commented: "This Agreement is integral to the distribution of our functionalised GNPsacross the global R&D market. The research departments served by Goodfellow arethe first step in the adoption of any new material, and this Agreement marks asignificant step forward in demonstrating the improved material properties thatour functionalisation method achieves. The endorsement as a supplier toGoodfellow represents a significant step forward for us, and we are delightedthat they have agreed to list our GNP product." "Goodfellow's extensive customer base will be instrumental in achieving greateraccess and visibility for our HDPlas® range. This will allow more R&D customersworldwide to test the improvement in product performance obtained by addingGNPs functionalised via our plasma process. We look forward to working closelywith them to deliver the HDPlas® range internationally." Stephen Aldersley, Managing Director of Goodfellow, believes that the newrelationship with Haydale is an important expansion of Goodfellow's activitiesin the field of nanoparticles in general and graphene in particular. Commentingon the Agreement, he said: "The Haydale plasma process can demonstrate significant advantages over otherfunctionalisation methods, and we are pleased to be promoting their products toour global customer base in this very important research area. We are alwayslooking for new, unique materials and the Haydale offering is certainly onethat meets our strict criteria." - ends - For further information please contact: Haydale Graphene Industries plc 01269 842 946 John Knowles, Chairman Ray Gibbs, Chief Executive Officer Cairn Financial Advisers LLP (Nomad) 0207 148 7900 Tony Rawlinson Paul Trendell Cantor Fitzgerald Europe (Broker) 020 7894 7000 David Foreman Paul Jewell Hermes Financial PR Trevor Phillips 07889 153 628 Chris Steele 07979 604 687 About Haydale Haydale has developed a patent-pending proprietary scalable plasma process tofunctionalise graphene and other nanomaterials. This enabling technology canprovide Haydale with a rapid and highly cost-efficient method of supplyingtailored solutions to enhance applications for both raw material suppliers andproduct manufacturers. Functionalisation is carried out through a low-pressure plasma process thattreats both mined, organic fine powder and other synthetically producednanomaterial powders, producing high-quality few layered graphenes and graphenenanoplatelets. The process can functionalise with a range of chemical groups,with the level of functionalisation tailored to the customer's needs. Gooddispersion improves the properties and performance of the host material andensures the final product performs as specified. The Haydale plasma process does not use wet chemistry, nor does it damage thematerial being processed; rather, it can clean up any impurities inherent inthe raw material. The technology is a low energy user and most importantlyenvironmentally friendly. The Haydale method is an enabling technology,allowing the Company to work with a raw material producer who seeks to addvalue to the base product and tailor the outputs to meet the targetapplications of the end user. Haydale, based in South Wales and housed in a purpose-built facility forprocessing and handling nanomaterials, is facilitating the application ofgraphenes and other nanomaterials in fields such as inks, sensors, energystorage, photovoltaics, composites, paints and coatings. www.haydale.com About Goodfellow For more than 45 years, the Goodfellow name has been synonymous with smallquantities of high-quality metals, polymers, ceramics and other materials thatmeet the research, development, and specialised production requirements ofscience and industry worldwide. The Goodfellow catalogue contains over 70,000products available for rapid shipment to customers worldwide. Standard productscan be found online at the comprehensive Goodfellow Catalogue(www.goodfellow.com). In addition to the standard products, Goodfellow is ableto offer non-standard products to the customer's specifications as well asmaterials in larger quantities for the production requirements of high-techindustry. The Goodfellow Group of companies consists of Goodfellow CambridgeLimited (UK), Goodfellow Corporation (USA), Goodfellow SARL (France),Goodfellow GmbH (Germany) and Goodfellow Shanghai (China).
Date   Source Headline
10th Apr 20177:00 amRNSIssue of Equity and Total Voting Rights
10th Apr 20177:00 amRNSIssue of Shares
31st Mar 20174:00 pmRNSIssue of Equity and Total Voting Rights
31st Mar 20177:00 amRNSIssue of Shares
27th Mar 20175:05 pmRNSTR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES
22nd Mar 20177:00 amRNSInterim Results
15th Mar 20177:00 amRNSFour-year supply agreement
7th Mar 20177:00 amRNSIssue of Shares
20th Feb 20177:00 amRNSIssue of Shares
3rd Feb 20177:01 amRNSProposed Strategic Investment
3rd Feb 20177:00 amRNSTrading update & Notice of results
16th Jan 201711:45 amRNSDirector Dealing
23rd Dec 20167:00 amRNSIssue of Shares
15th Dec 20163:00 pmRNSResult of AGM
15th Dec 20167:00 amRNSAGM Statement
28th Nov 20167:00 amRNSAgreement with Huntsman Advanced Materials
22nd Nov 20167:00 amRNSAnnual Financial Report
19th Oct 20167:00 amRNSPDMR Dealings
18th Oct 20167:00 amRNSPDMR Dealings
17th Oct 20167:00 amRNSGrant of Options
13th Oct 20167:00 amRNSDistribution Agreement
13th Oct 20167:00 amRNSPDMR Dealings
11th Oct 20167:00 amRNSResult of Open Offer and Total Voting Rights
28th Sep 20167:00 amRNSContract Extension
23rd Sep 201610:57 amRNSResult of Placing
23rd Sep 20167:01 amRNSFinal Results
23rd Sep 20167:00 amRNSProposed Acquisition and Fundraise
9th Sep 20164:05 pmRNSCompletion of Innophene Acquisition
26th Aug 20167:00 amRNSDirector/PDMR Shareholding
25th Aug 20167:00 amRNSAcquisition and Issue of Equity
11th Aug 20167:00 amRNSGraphene Enhanced PLA Filaments for 3D Printing
8th Aug 20167:00 amRNSHaydale Funds New Professorial Chair Within WCPC
29th Jul 20167:00 amRNSBoard Change
7th Jun 201610:42 amRNSGrant of Warrants
26th May 20167:00 amRNSAgreement with Flowtite Technology AS
20th May 20163:27 pmRNSDirector Dealing
20th May 20167:00 amRNSGrant of Options
18th May 20167:00 amRNSReactor Supply and Collaboration Agreement
9th May 20167:00 amRNSInvestor Open Day
25th Apr 20164:40 pmRNSHolding(s) in Company
7th Apr 201611:28 amRNSCorrection: Joint Development & Supply Agreement
7th Apr 20167:00 amRNSJoint Development and Supply Agreement
22nd Mar 20167:00 amRNSHalf Yearly Report
14th Mar 20167:00 amRNSGraphene Enhanced Composite Products Launched
8th Mar 201611:12 amRNSNotice of Results
16th Feb 20167:00 amRNSGrant Awards
4th Feb 20167:00 amRNSHaydale Commission Composite Pipe Testing Facility
3rd Feb 20167:00 amRNSAcquisition of Rights and Grant of Warrants
3rd Dec 201511:58 amRNSResult of AGM
1st Dec 201512:05 pmRNSDirector Dealing

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.